Showing results (581-590 of 861) with videos related to

Sort By:
Pageof 87
Lupus Science & Medicine|March 7, 2024
Mezagitamab in systemic lupus erythematosus: clinical and mechanistic findings of CD38 inhibition in an autoimmune diseaseScott R P McDonnell, Van Anh Nguyen, Noah M Walton, et al.
Lupus Science & Medicine|February 15, 2024
Clinical trial outcomes for SLE: what we have and what we needLaurent Arnaud, Ioannis Parodis, Hervé Devilliers, et al.
Lupus Science & Medicine|November 2, 2023
Effect of anti-P ribosomal and anti-NR2 antibodies on depression and cognitive processes in SLE: an integrated clinical and functional MRI studyElisabetta Chessa, Matteo Piga, Alessandra Perra, et al.
Lupus Science & Medicine|October 6, 2023
High-dimensional analysis of T-cell profiling variations following belimumab treatment in systemic lupus erythematosusShinji Maeda, Hiroya Hashimoto, Tomoyo Maeda, et al.
Lupus Science & Medicine|July 25, 2023
Improving resource utilisation in SLE drug development through innovative trial designSandra Garces, Elaine Karis, Joan T Merrill, et al.
Lupus Science & Medicine|May 30, 2023
Usefulness of the lupus low disease activity state as a treatment target in childhood-onset SLEEllen M Cody, Bridget E Wilson, Ekemini A Ogbu, et al.
Lupus Science & Medicine|March 11, 2026
Biomarker-stratified efficacy and safety of biologics in systemic lupus erythematosus: a systematic review and meta-analysisSafi G Alqatari, Mohanad A Alkuwaiti, Faisal A Al-Harbi, et al.
Lupus Science & Medicine|March 31, 2026
Pulmonary diseases in SLE: a population-based cross-sectional studyHenrik Zachar Langkilde, Jesper Davidsen, Stefan Harders, et al.
Lupus Science & Medicine|March 18, 2026
Twelve-month follow-up after telitacicept withdrawal in patients with SLE: a single-centre studyZhaoyang Fan, Yi Wei, Chunting Guo, et al.
Pageof 87